ATXS(Delisted)
Astria Therapeutics·NASDAQ
--
--(--)
Latest data update time: Updated on 2026-01-24
Latest data update time: Updated on 2026-01-24
5.23 / 10Overall Score
NeturalInvestment Rating
5.23 / 10Overall Score
NeturalInvestment Rating
Is ATXS a Good Buy Right Now?
- Based on a composite score of 5.23/10, we rate ATXS as a Netural. Our analysis breaks down into 6.71/10 for Fundamentals, 3.39/10 for Technicals, and 5.42/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of ATXS?
Is ATXS undervalued or overvalued?
Is money flowing into or out of ATXS?
Is ATXS a Good Buy Right Now?
- Based on a composite score of 5.23/10, we rate ATXS as a Netural. Our analysis breaks down into 6.71/10 for Fundamentals, 3.39/10 for Technicals, and 5.42/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is ATXS undervalued or overvalued?
Technical Analysis of ATXS?
Is money flowing into or out of ATXS?
